Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

I expect that Gerald will update the shareholders this week through his C.E.O. blog.

I bought shares yesterday and will add more on any dip lower.

The current share price is down about 65% from its recent high.

Risk/reward dictates adding/buying shares here.

A joint venture or partnership for the MANF technology could provide the company with a cash payment that would allow the development of Amarantus Diagnostics as a separate "internal" entity. It would also avoid additional dilution.

All IMHO.